首页> 美国卫生研究院文献>Springer Open Choice >Early Effects of Single and Low-Frequency Repeated Administration of Teriparatide hPTH(1-34) on Bone Formation and Resorption in Ovariectomized Rats
【2h】

Early Effects of Single and Low-Frequency Repeated Administration of Teriparatide hPTH(1-34) on Bone Formation and Resorption in Ovariectomized Rats

机译:单次和低频重复给予曲拉帕肽hPTH(1-34)对去卵巢大鼠骨形成和吸收的早期影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Intermittent repeated administration of teriparatide (TPTD) has potent anabolic effects on bones in vivo. However, TPTD has both anabolic and catabolic effects on osteoblasts in vitro, and the mechanisms underlying its promotion of bone formation are unclear. This study aimed to elucidate the time-dependent changes in bone formation and resorption by examining changes in bone turnover markers and bone tissue over time after TPTD administration with low frequency in ovariectomized rats. The amount of serum osteocalcin, a bone formation marker, was transiently reduced after single TPTD administration, but increased thereafter, remaining increased for several days. In contrast, the amount of excreted urinary C-telopeptide, a bone resorption marker, increased transiently after single TPTD administration, and subsequently returned to control levels on the day after administration. Tissue histomorphometric analyses conducted 8 h after administration showed no changes in bone formation or bone resorption parameters. However, at 48 h, the bone formation parameters OS/BS and Ob.S/BS were increased, while the bone resorption parameter ES/BS was decreased. After repeated TPTD administration for 4 weeks, OS/BS, Ob.S/BS, and MS/BS increased, while Oc.S/BS decreased. Serum osteocalcin at 4 weeks after repeated administration was significantly correlated with OS/BS and Ob.S/BS. These present findings indicate that TPTD has dual, time-dependent effects on bone resorption and bone formation. Immediately after single administration, there was transient promotion of bone resorption and suppression of bone formation. However, sustained stimulation of bone formation occurred thereafter. Furthermore, these data suggest that this sustained bone formation led to anabolic effects with repeated TPTD administration.
机译:特立帕肽(TPTD)的间歇性重复给药对体内骨骼具有强大的合成代谢作用。然而,TPTD在体外对成骨细胞具有合成代谢和分解代谢作用,其促进骨形成的机制尚不清楚。这项研究旨在通过在去卵巢大鼠中以低频率进行TPTD给药后检查骨转换标志物和骨组织随时间的变化来阐明骨形成和吸收的时间依赖性变化。单一TPTD给药后,血清骨钙素(一种骨形成标志物)的量暂时减少,但此后增加,并持续数天。相反,排泄的尿C-端肽(一种骨吸收标记)的量在单次TPTD给药后短暂增加,随后在给药后第二天恢复到对照水平。给药后8小时进行组织组织形态分析,结果显示骨形成或骨吸收参数无变化。但是,在48小时时,骨形成参数OS / BS和Ob.S / BS增加,而骨吸收参数ES / BS降低。重复TPTD管理4周后,OS / BS,Ob.S / BS和MS / BS增加,而Oc.S / BS减少。重复给药后4周血清骨钙蛋白与OS / BS和Ob.S / BS显着相关。这些目前的发现表明,TPTD对骨吸收和骨形成具有双重的,时间依赖性的影响。单次给药后,立即促进骨吸收并抑制骨形成。然而,此后发生了持续的骨形成刺激。此外,这些数据表明,这种持续的骨形成导致了重复施用TPTD的合成代谢作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号